SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (2250)10/18/2006 3:44:26 PM
From: rkrw  Read Replies (1) | Respond to of 3158
 
Exel stated goal is to be a top-5 biotech, so that would place them at celgene/genz or $18B, so more like an 1800% premium :-)

exel spends too much for mlnm to take on. exel is a bio that should be left alone. 15 (?) drugs into the clinic by the end of next year. Would ruin the fun to see them get munched.